Team:Paris Bettencourt/BioBricks

Add abstract and hyperlink to BioBricks in the Parts Registry

   TDMH is a trehalose 6,6’ dimycolate (TDM) esterase serine esterase superfamily that can hydrolyze purified TDM from various mycobacterial species. TDM is one of the most potent immunomodulatory and granulomatogenic surface glycolipids and it is highly abundant in at least ten species of pathogenic and non-pathogenic mycobacteria. Additonally TDM is crucial to the structural integrity of the mycobacterial envelope. As such, TDMH triggers rapid and extensive lysis of mycobacterial species due to the release of free mycolic acids from the non-covalently associated mycolyl-containing glycolipids.

   This complex part contains everything necessary to express small RNA to inhibit expression of the Kanamycin resistance cassette encoding Aminoglycoside N6'-acetyltransferase. The biobrick contains a Pr promoter, target sRNA, a scaffold derived from MicC lacking the ompC binding sequence, and a T1/TE terminator. The scaffold forms the RNA secondary structure while the target sRNA of the sequence CGTTTCCCGTTGAATATGGCT binds to the target sequence of ATGAGCCATATTCAACGGGAAACG including the start codon and the first 24 bp of the kanamycin ORF within the mRNA. It is vital that the sequences are complementary for proper repression to occur. If there are point mutations within a copy of the kanamycin resistance cassette at this location, or a different kanamycin cassette is targeted the biobrick will not function correctly.

This complex part contains everything necessary to express small RNA to inhibit expression of the Chloramphenicol resistance cassette cat encoding chloramphenicol acetyltransferase. Very similar to BBa_K1137010, the biobrick contains a Pr promoter, target sRNA, a scaffold derived from MicC lacking the ompC binding sequence, and a T1/TE terminator. The scaffold forms the RNA secondary structure while the target sRNA of the sequence ATATCCAGTGATTTTTTTCTC binds to the target sequence of ATGGAGAAAAAAATCACTGGATAT which includes the start codon and the first 24 bp of the ORF within the chloramphenicol mRNA. As above, it is vital that the sequences are complementary for proper repression to occur. If there are point mutations within a copy of the cat cassette at this location, or a different mechanism provides chloramphenicol resistance the biobrick will not function correctly.

   Highly similar to BBa_K1137009 and BBa_K1137010, this part contains everything necessary to express small RNA to inhibit expression of lacZ. The biobrick contains a Pr promoter, target sRNA, a scaffold derived from MicC lacking the ompC binding sequence and a T1/TE terminator. The scaffold forms the RNA secondary structure while the target sRNA of the sequence CAGTGAATCCGTAATCATGGT bind to the target sequence of ATGACCATGATTACGGATTCACTG which includes the start codon and the first 24 bp of the ORF within the lacZ mRNA. As in the previously described biobricks, it is vital that the sequences are complementary for proper repression to occur. If there are point mutations within the lacZ gene or biobrick sequence the biobrick will not function correctly. Additionally, there will be some leakage of β-Galactosidase which will cause cleavage of X-Gal, however we observed that edges of colonies tended to be white while the center of colonies tended to be blue.

   This biobrick encodes a Ferredoxin-dependent sulfite reductase SirA, which reduces sulfite to hydrogen sulfide in the cysteine metabolism pathway. Due to the sensitivity of sulfur contain amino acids to oxidative stress; they must constantly be replenished in mycobacteria while inside the phagosome. Thus sirA is one of the few genes that is upregulated even in latent mycobacterial infections. Additionally, SirA differs from E. coli and Human sulfite reductases in its use of ferredoxin as an electron done instead of NADPH. As a result sirA has been previously identified as a drug target candidate for M. Tuberculosis infections. SirA reduces sulfite in the following reaction (EC=1.8.7.1):

   This biobrick encodes a NADPH-ferredoxin reductase FprA. This replenishes FdxA by reducing it with NADPH as an electron donor and is required for the proper function of BBa_K1137000 along with BBa_K1137001 in the following reaction (EC=1.18.1.2):

   This biobrick encodes a 7Fe ferredoxin which is an orthologue of ferredoxin FdxC in M. Tuberculosis. It contains both one 3Fe-4S and one 4Fe-4S cluster. FdxA is the preferred substrate of FprA and is required for the proper functioning of SirA for sulfite reduction during cysteine metabolism.

   This rather simple part contains the UG6 promoter that controls the gRNA anti KAN cassette. This cassette consists of a seed sequence of the Kanamycin resistance gene (Aminoglycoside N6’-acetyltransferase) and the gRNA scaffold. This part is ready to use and can generate together with the CAS9 a double strand break in the kanamycin resistance gene. By definition, the gRNA is hybrid RNA out of the crRNA and tracrRNA. The gRNA is necessary to guide the CAS9 to the specific site and to cause there a double strand break. The design of the gRNA is taken from the DiCarlo et al. 2013 paper.